Downregulation of ABCG2/Abcg2 was found to impair the barrier function of the intestine, thus leading to higher carcinogen concentrations in colorectal adenomas in mice and humans and promoting the adenoma–carcinoma sequence via DNA-bound accumulation of carcinogenic xenobiotics. The gene discussed is ABCG2; the disease is adenoma.